Clinical role of p16INK4a expression in liquid-based cervical cytology : Correlation with HPV testing and histologic diagnosis

American Journal of Clinical Pathology

Volumn 129, Issue 4, 2008, Pages 606-612

  Benevolo, Maria ^a   Vocaturo, Amina ^a   Mottolese, Marcella ^a   Mariani, Luciano ^a   Vocaturo, Giuseppe ^a   Marandino, Ferdinando ^a   Sperduti, Isabella ^a   Rollo, Francesca ^a   Antoniani, Barbara ^a   Donnorso, Raffaele Perrone ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervicovaginal cytology; High grade squamous intraepithelial lesion; Human papillomavirus; Hybrid capture 2; p16INK4a; ThinPrep

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRECANCER; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VERRUCA VULGARIS; WART VIRUS; GENETICS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PAPILLOMA VIRUS; PREDICTION AND FORECASTING; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 42949128170     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/BEPQXTCQD61RGFMJ     Document Type: Article

References (22)

1. Sahebali S, Depuydt CE, Boulet GAV, et al. Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer. 2006;118:1254-1260.
2. Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med. 2003;127:959-968.
3. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
4. Daltein V, Riethmuller D, Pretet J-L, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003;106:396-403.
5. INK4a is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol. 2006;19:384-391.
6. Moore GD, Lear SC, Wills-Frank LA, et al. Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method. Diagn Cytopathol. 2005;32:82-87.
7. INK4a is a surrogate biomarker for a subset of human papillomavirus-associated dysplasias of the uterine cervix as determined on the Pap smear. Diagn Cytopathol. 2005;32:21-24.
8. INK4a expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer Cytopathol. 2006;108:119-123.
9. INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer. 2004;108:871-876.
10. Guo M, Hu L, Baliga M, et al. The predictive value of p16 and Hybrid Capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2004;122:894-901.
11. Yoshida T, Fukuda T, Sano T, et al. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing. Cancer Cytopathol. 2004;102:100-108.
12. INK4a immunolocalization with the presence of human papillomavirus by Hybrid Capture 2 for the detection of cervical dysplasia/neoplasia. Cancer Cytopathol. 2006;108:451-461.
13. INK4a assay. Cancer Cytopathol. 2007;111:83-92.
14. Solomon D, Davey D, Kurman R, et al; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
15. INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high risk HPV types. Mod Pathol. 2003;16:665-673.
16. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley; 1981.
17. INK4a in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol. 2002;27:365-370.
18. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer. 2002;38:2229-2242.
19. INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
20. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002;52:375-383.
21. Mottolese M, Nadasi EA, Botti C, et al. Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer. J Cell Physiol. 2005;204:106-112.
22. Snijders PJF, van den Brule AJC, Meijer CJLM. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201:1-6.